Skip to content
healthcare.dev

Loratadine

NDC 16571-822, loratadine, tablet, from Rising Pharmaceuticals, Inc.

Product NDC
16571-822
Status
Listed
Labeler
Rising Pharmaceuticals, Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA214684
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-822 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
Package NDCNDC-11Package
16571-822-0116571082201100 TABLET in 1 BOTTLE (16571-822-01)
16571-822-031657108220330 TABLET in 1 BOTTLE (16571-822-03)
16571-822-3016571082230300 TABLET in 1 BOTTLE (16571-822-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 16571082201

    GET /v1/drugs/nadac/16571082201
  • NADAC price for package 16571082203

    GET /v1/drugs/nadac/16571082203
  • NADAC price for package 16571082230

    GET /v1/drugs/nadac/16571082230

Use it

Look up 16571-822 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-822 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-822. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.